New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.
about
Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammationThe Impact of Immunosenescence on Pulmonary DiseaseSIRT1 as a therapeutic target in inflammaging of the pulmonary diseaseOxidative stress and free radicals in COPD--implications and relevance for treatmentSenescence in chronic obstructive pulmonary diseaseOccupational exposures and longitudinal lung function declineMolecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a reviewEarly-age-related changes in proteostasis augment immunopathogenesis of sepsis and acute lung injury.Cigarette smoke exposure aggravates air space enlargement and alveolar cell apoptosis in Smad3 knockout mice.Influencing the decline of lung function in COPD: use of pharmacotherapy.Immunochemical detection of oxidatively damaged DNA.Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrowSuppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.Neutrophil elastase inhibitors.Role of AMP-Activated Protein Kinase (AMPK) in Smoking-Induced Lung Inflammation and Emphysema.FOXO3 deficiency leads to increased susceptibility to cigarette smoke-induced inflammation, airspace enlargement, and chronic obstructive pulmonary diseaseHIV and chronic obstructive pulmonary disease: is it worse and why?Oxidants in Acute and Chronic Lung DiseaseSOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development.The pathogenesis of COPD and IPF: distinct horns of the same devil?Stress responses affecting homeostasis of the alveolar capillary unit.Blocking NF-κB: an inflammatory issue.SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice.Changes in chemiluminescence of whole blood of COPD patients treated with Hypoxen and effects of C₆₀ fullerenes on blood chemiluminescence.Isolation and characterisation of human pulmonary microvascular endothelial cells from patients with severe emphysemaInvolvement of B-cell CLL/lymphoma 2 promoter methylation in cigarette smoke extract-induced emphysema.SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD.Therapeutic effects of adipose-derived stem cells pretreated with pioglitazone in an emphysema mouse model.Gene Profiles in a Smoke-Induced COPD Mouse Lung Model Following Treatment with Mesenchymal Stem Cells.Emphysema classification based on embedded probabilistic PCA.Regulation of SIRT1 in cellular functions: role of polyphenolsLung disease associated with alpha1-antitrypsin deficiency.Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.Role of Apoptosis in Amplifying Inflammatory Responses in Lung DiseasesAbnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products.Mitochondrial dysfunction in inflammatory responses and cellular senescence: pathogenesis and pharmacological targets for chronic lung diseases.Nano-based rescue of dysfunctional autophagy in chronic obstructive lung diseases.Role of Inflammation and Oxidative Stress in the Pathology of Ageing in COPD: Potential Therapeutic Interventions.Non-infectious pulmonary disorders in HIV.
P2860
Q24615052-B7789224-1234-4728-8FDD-079A01EB3855Q26801157-71A7E709-1A83-499D-8B33-65B7BF8C0362Q26829351-CD832163-B5A5-4790-AFB1-C2661A24D3FCQ26830076-608675C9-44F6-4D25-BC36-0D4C95D16D37Q27014861-87198CEA-2234-4EF0-B104-EF04635CDA50Q28384233-F3A8560F-D4B9-4AC2-9F36-1A6057CF9194Q28390078-91C3678D-39B1-4F76-89E2-4BEFDCC8A2C3Q33749929-D5455EFD-F160-4CF1-81E5-E107F2537798Q33956709-04C41EA1-2FEE-4C0E-AAF6-932E0CA94438Q33966001-C331915D-3C12-4322-B842-5EEADD56ED3EQ34228272-9065AEEA-5A63-4BEE-8F2C-91E0437035A1Q34261568-080FD055-CC4A-4B71-9400-4E5D7037479BQ34350843-9FF4A0E7-A3EB-4285-B83B-F266A7A72AD4Q34814104-CCC46943-B998-47B9-B3F4-E3F79EB01251Q35028796-C440762B-E109-4A4B-BF74-5AD26CFC9692Q35091274-790A7FE3-75FB-47CA-A001-02308247D964Q35095058-2A0DFFE1-A62D-4811-BFF3-2DF21FF79558Q35104183-7CB50453-062E-4D19-B9DB-E94CFD1CFAADQ35107672-ADB2E766-1257-4B6A-876C-A78E89AE9BC9Q35766351-F0462FD8-F0E2-466D-8431-2BEEE6A9BA0AQ35983853-4C4920A4-9254-4699-AF4C-A951FAB16826Q35983857-5583EC43-533D-435A-9327-AC7B953284A2Q36005375-36F79C7D-664A-4658-84DC-79F82F25BF55Q36576890-F19D8DE9-58DE-41AF-9281-EE959F23673CQ36688641-BCEF81C8-1394-461A-B9D4-096268F9E704Q37107240-F0305C98-58F0-4DEE-88A7-57AE7676CFC0Q37342209-62693316-DC9E-42B9-8094-D5D79D89B7B2Q37399408-DA10CD01-2667-4AF1-85E8-A2AE0DBE55C3Q37408240-6A106ED5-99FD-44D4-918F-244B35D0DE68Q37570285-A01C683F-48C6-4AAD-BA7D-906C87F0FE56Q37745178-3B1470B2-E9D2-4B87-B065-95C81451B95AQ37804626-7545CB2E-83C5-417E-8076-C7FDFDAB4D87Q37836078-27522908-AB2A-4D79-9A9E-2F9C913EE307Q37955890-8A23156D-CE38-4BE2-92DC-C3C4C7BD8C4CQ38009797-977FE84B-F3BC-4B22-BBEC-A06284F78985Q38066244-9A1864F5-0DE0-43CB-AB5A-FA93348BD1E7Q38836727-CC27009D-6BCE-4FE0-858B-50245F0AF0DAQ38937131-6E8AB077-4876-471B-AD49-DE4461DB0133Q38953736-02642043-5D96-454F-A9B1-D0A4A1F2172FQ39106214-6A42962A-BBB6-4147-89AF-7CBF4D3449D2
P2860
New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.
@en
New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.
@nl
type
label
New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.
@en
New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.
@nl
prefLabel
New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.
@en
New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.
@nl
P1476
New paradigms in the pathogenesis of chronic obstructive pulmonary disease I.
@en
P2093
Rubin M Tuder
P304
P356
10.1513/PATS.200905-027DS
P577
2009-09-01T00:00:00Z